Mayer, L. D., Tardi, P., & Louie, A. C. (2019). CPX-351: A nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties. Int J Nanomedicine.
Citação norma ChicagoMayer, Lawrence D., Paul Tardi, and Arthur C. Louie. "CPX-351: A Nanoscale Liposomal Co-formulation of Daunorubicin and Cytarabine With Unique Biodistribution and Tumor Cell Uptake Properties." Int J Nanomedicine 2019.
Citação norma MLAMayer, Lawrence D., Paul Tardi, and Arthur C. Louie. "CPX-351: A Nanoscale Liposomal Co-formulation of Daunorubicin and Cytarabine With Unique Biodistribution and Tumor Cell Uptake Properties." Int J Nanomedicine 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.